Pfizer Sues India’s Alembic Over Generic Pain-Drug Lyrica

Pfizer Inc. (PFE), the world’s largest drugmaker, sued India’s Alembic Ltd. (ALBC) in federal court in Delaware asking a judge to block generic sales of the pain drug Lyrica until a U.S. patent expires in 2018.

To contact the reporter on this story: Phil Milford in Wilmington, Delaware at pmilford@bloomberg.net

To contact the editor responsible for this story: Mary Romano at mromano6@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.